In vivo, TMEM106B has opposing effects in mouse models of lysosomal diseases where it was found that TMEM106B differentially modulates the progression of the lysosomal storage diseases Gaucher disease and neuronal ceroid lipofuscinosis [23]. This evidence concerns the gene TMEM106B and infantile neuronal ceroid lipofuscinosis.